Warfarin monitoring in patients with anticardiolipin antibodies, but without lupus anticoagulants

Thrombosis Research

Volumn 99, Issue 5, 2000, Pages 477-482

  Mant, Michael J ^a,b   Stang, Linda ^a   Etches, Wai S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anticardiolipin antibody; Anticoagulation; Lupus anticoagulant; Prothrombin time; Thromboplastin; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PT FIBRINOGEN; RECOMBINANT THROMBOPLASTIN; THROMBOPLASTIN; THROMBOPLASTIN C PLUS; WARFARIN;

ANTIBODY TITER; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TEST; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERNATIONAL STANDARD UNIT; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; ANTIBODIES, ANTICARDIOLIPIN; BLOOD COAGULATION TESTS; DRUG MONITORING; HUMANS; INTERNATIONAL NORMALIZED RATIO; LUPUS COAGULATION INHIBITOR; REAGENT KITS, DIAGNOSTIC; RECOMBINANT PROTEINS; THROMBOPLASTIN; WARFARIN;

EID: 0034283111     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00279-6     Document Type: Article

References (14)

1. Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Moffatt K, Johnston M, Stevens P, Hirsh J. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86: 3685-91.
2. Simioni P, Prandoni P, Zanon E, Saracino MA, Scudeller A, Villalta S, Scarano L, Girolami B, Benedetti L, Girolami A. Deep venous thrombosis and lupus anticoagulant. A case-control study. Thromb Haemost 1996;76: 187-9.
3. Schulman S, Svenungsson E, Granqvist S, and the Duration of Anticoagulation Study Group. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med 1998;104:332-8.
4. Kittner SJ, Gorelick PB. Antiphospholipid antibodies and stroke: An epidemiological perspective. Stroke 1992;23(Suppl 1):19-22.
5. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303-8.
6. Khamashta MA, Cuandrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332:993-7.
7. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999;353:1348-53.
8. Della Valle P, Crippa L, Safa O, Tomassini L, Pattarini E, Vigano-D'Angelo S, Grazia Sabbadini M, D'Angelo A. Potential failure of the international normalized ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants. Ann Intern Med 1996;147(Suppl 1):10-4.
9. Low J, Joseph J, Concannon A. INR discrepancies with a recombinant thromboplastin in two patients with the antiphospholipid syndrome. Thromb Haemost 1997;78(Suppl 1):701-2.
10. Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997;127:177-85.
11. Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome. Br J Hematol 1997;98:887-92.
12. Robert A, Le Querrec A, Delahousse B, Caron C, Houbouyan L, Boutière B, Horellou MH, Reber G, Sié P for the Groupe "Méthodologie en Hémostase" du Groupe d'Etudes sur l'Hémostase et la Thrombose. Control of oral anticoagulation in patients with the antiphospholipid syndrome - Influence of the lupus anticoagulant on international normalized ratio. Thromb Haemost 1998;80:90-103.
13. Triplett DA. Lupus anticoagulants/antiphospholipid-protein antibodies: The great imposters. Lupus 1996;5:431-5.
14. Stewart MW, Etches WS, Russell AS, Percy JS, Johnston CA, Chew CK, Gordon PA. Detection of antiphospholipid antibodies by flow cytometry: Rapid detection of antibody isotype and phospholipid specificity. Thromb Haemost 1993;70:603-7.